OUR BUSINESS
*Morphed with Financial sustainability risk in the 2021 annual integrated report
Risk
Description
Y-o-Y movement 2022
Y-o-Y movement 2021
Strategic objective
Capitals
Residual Risk
High
Level of Control
Impact of adverse financial audit opinions
N/A
Inability to meet all demand for all blood products
Inability to remain financially sustainable
Medium
Failure to provide and maintain stable information management systems
Ability to maintain R&D leading to new products/new solutions and new income streams (Opportunity)
Compromised safety and quality of blood products
Uncertainty as to the impact of the National Health Insurance (NHI) implementation on SANBS operations
Internal and external events that may compromise the SANBS brand
Non-compliance with regulatory requirements
Poor procurement practices that may impact negatively on internal service delivery